Sunshine Biopharma gets Canadian approval for enalapril
Sunshine Biopharma (SBFM) says it received Canadian regulatory approval for enalapril, positioning the company to expand within a stated $25.94 billion global anti-hypertensive drug market.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
SBFM Receives Approval
Sunshine Biopharma receives Canadian regulatory approval for generic Arimidex